Article Details
Retrieved on: 2018-01-03 20:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>CAMBRIDGE, Mass.--(BUSINESS WIRE)--<b>Atlas Venture</b>, a leading biotech venture capital firm, today announced the launch of Generation Bio, a company developing the first genetic medicines that can be titrated to effect and re-dosed for a lifetime of benefit. Atlas founded the company in 2016 with a ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here